Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome

The coronavirus disease 2019 (COVID-19) pandemic has heavily challenged the global healthcare system. Despite the vaccination programs, the new virus variants are circulating. Further research is required for understanding of the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Antiviral research 2024-03, Vol.223, p.105813-105813, Article 105813
Hauptverfasser:	Bogacheva, Mariia S., Kuivanen, Suvi, Potdar, Swapnil, Hassinen, Antti, Huuskonen, Sini, Pöhner, Ina, Luck, Tamara J., Turunen, Laura, Feodoroff, Michaela, Szirovicza, Leonora, Savijoki, Kirsi, Saarela, Jani, Tammela, Päivi, Paavolainen, Lassi, Poso, Antti, Varjosalo, Markku, Kallioniemi, Olli, Pietiäinen, Vilja, Vapalahti, Olli
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Biological Assay Cell Death Chlorocebus aethiops COVID-19 Drug Repositioning Drug repurposing High-throughput drug screening Humans Image-based data analysis Nucleocapsid Proteins SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!